Press Releases
Current Press Releases regarding Schwabe Pharmaceuticals
.
Press Releases
-
St. John's Wort extract WS® 5570 is at least as effective as paroxetine in the treatment of moderate to severe major depression
KARLSRUHE, Germany, 11 February 2005. According to latest research, Dr. Willmar Schwabe Pharmaceuticals' proprietary St. John's Wort extract WS® 5570 is at least as effective and better tolerated than standard treatment with prescription antidepressant paroxetine in the treatment of moderate to severe major depression.
-
Does taking Ginkgo special extract EGb 761® protect against Alzheimer's?
KARLSRUHE, Germany, 6 August 2004. An epidemiological study in France has revealed interesting results about the role of Ginkgo special extract EGb 761® in the prevention of Alzheimer's disease.
-
Ginkgo biloba extract EGb 761® enhances cognitive performance of healthy older adults
KARLSRUHE, Germany, 15 May 2003. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761® in a sample of cognitively intact older adults
-
Ginkgo extract EGb 761® inhibits the formation of "Alzheimer plaques"
KARLSRUHE, Germany, 11 September 2002. Inhibition of amyloid-ß aggregation and apoptosis by Ginkgo biloba extract EGb 761® in vitro. PNAS, 2002, Vol 99, No. 19, 12197-12202
Read On
;){kind=link}
;){kind=link}
Path Navigation
Main Navigation
Latest News
Major study shows that long-term intake of Ginkgo biloba special extract EGb 761® protects against Alzheimer's disease
Read more
Footer Navigation
Service Navigation
Help
You can change the Font Size here:
Font Size